4 results on '"Guitton Bliem C"'
Search Results
2. Prise en charge des allo-immunisations fœto-maternelles antiérythrocytaires
- Author
-
Bricca, P., Guinchard, E., and Guitton Bliem, C.
- Published
- 2011
- Full Text
- View/download PDF
3. [Management of feto-maternal red cell allo-immunizations].
- Author
-
Bricca P, Guinchard E, and Guitton Bliem C
- Subjects
- Amniotic Fluid chemistry, Blood Flow Velocity, Blood Group Antigens analysis, Blood Group Antigens genetics, Blood Group Antigens immunology, Blood Group Incompatibility diagnosis, Blood Group Incompatibility embryology, Blood Grouping and Crossmatching methods, Blood Transfusion, Intrauterine, Erythroblastosis, Fetal etiology, Erythroblastosis, Fetal immunology, Erythroblastosis, Fetal therapy, Erythrocyte Transfusion, Female, Fetal Blood immunology, Fetal Death etiology, Fetal Death prevention & control, Fetal Diseases blood, Fetal Diseases diagnostic imaging, Fetal Diseases etiology, Fetal Diseases immunology, Humans, Hyperbilirubinemia, Neonatal etiology, Hyperbilirubinemia, Neonatal immunology, Infant, Newborn, Isoantibodies administration & dosage, Isoantibodies immunology, Isoantibodies therapeutic use, Middle Cerebral Artery diagnostic imaging, Middle Cerebral Artery embryology, Pregnancy, Prenatal Care methods, Prenatal Care standards, Rh Isoimmunization etiology, Rh Isoimmunization immunology, Rh Isoimmunization prevention & control, Rho(D) Immune Globulin, Ultrasonography, Prenatal methods, Blood Group Incompatibility immunology, Erythroblastosis, Fetal prevention & control, Erythrocytes immunology, Fetal Diseases prevention & control, Fetomaternal Transfusion immunology, Hyperbilirubinemia, Neonatal prevention & control, Isoantibodies blood
- Abstract
Feto-maternal red cell alloimmunization is defined by the presence in a pregnant woman of alloantibodies directed against blood group antigens present on the red blood cells of the fetus and inherited from the father. It arises from the immune response to a first contact to these same antigens during a prior transfusion, transplant or pregnancy. The placental transfer and the fixation of the antibodies on the fetal red cells antigenic targets lead to a haemolysis in the fetus and the newborn. The resulting haemolytic disease can show different clinical forms, from a mild anaemia with neonatal hyperbilirubinemia to a major fetal damage with stillbirth caused by hydrops fetalis. The objective of management strategies of feto-maternal alloimmunization is to detect and monitor maternal alloimmunization and to appreciate the effects on the fetus or the newborn. Since a few years, some new non-invasive techniques of surveillance are used, for instance fetal RHD genotyping on maternal plasma and evaluation of fetal anaemia through velocimetry measurement of the blood flow in the middle cerebral artery. The need for a careful postnatal surveillance has to be emphasized due to the neonatal anaemia, which can be prolonged, and to the resurgence of cases of severe neonatal icteruses recently reported by the Académie de Médecine. The policy of prevention of anti-RH1 alloimmunization should also benefit from the evolution of biological techniques by allowing an improved targeting of concerned women., (Copyright © 2011 Elsevier Masson SAS. All rights reserved.)
- Published
- 2011
- Full Text
- View/download PDF
4. [Medical biology accreditation at EFS].
- Author
-
Trapadoux F, Guitton Bliem C, Hergon E, and Roubinet F
- Subjects
- Accreditation legislation & jurisprudence, Clinical Laboratory Information Systems legislation & jurisprudence, Clinical Laboratory Information Systems standards, Documentation standards, Forms and Records Control legislation & jurisprudence, Forms and Records Control standards, France, Hospital Records legislation & jurisprudence, Hospital Records standards, Laboratories legislation & jurisprudence, Laboratories organization & administration, Laboratories, Hospital legislation & jurisprudence, Laboratories, Hospital organization & administration, Laboratories, Hospital standards, Medical Laboratory Personnel legislation & jurisprudence, Medical Laboratory Personnel standards, Medical Records Systems, Computerized legislation & jurisprudence, Medical Records Systems, Computerized standards, Professional Competence legislation & jurisprudence, Professional Competence standards, Quality Improvement, Risk Management legislation & jurisprudence, Risk Management standards, Accreditation standards, Laboratories standards, Societies, Medical standards
- Abstract
The medical biology laboratory accreditation according to the Iso 15189 standard, which main lines are mentioned in the article, is henceforth becoming a statutory obligation in France. All laboratories must apply, at least partly, to the COFRAC, by 31(st) October 2012. The EFS has largely anticipated the necessary steps to reach this objective and has developed an approach based on six basic processes. To date, 24 laboratories of various technical fields are accredited and several other submissions are pending. The Iso 15189 standard requirements match those already implemented at the EFS with the Certification. The trade standard operating procedures are almost included in the risk control management. Through the involvement of all the EFS members following precision action plans based on the sharing of successful experiences and the harmonization of trade practices, this compulsory objective will be reached and the deadline respected., (Copyright © 2011 Elsevier Masson SAS. All rights reserved.)
- Published
- 2011
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.